Prevention and treatment of colon cancer by peroral administration of HAMLET (human α-lactalbumin made lethal to tumour cells)

Gut

Volumn 63, Issue 1, 2014, Pages 131-142

  Puthia, Manoj ^a   Storm, Petter ^a   Nadeem, Aftab ^a   Hsiung, Sabrina ^a   Svanborg, Catharina ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; HUMAN ALPHA LACTALBUMIN MADE LETHAL TO TUMOR CELL; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MORTALITY; CANCER PREVENTION; COLON CANCER; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG RESPONSE; GENE EXPRESSION; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; WNT SIGNALING PATHWAY;

CANCER PREVENTION; COLONIC ADENOMAS; COLONIC POLYPS; COLORECTAL CANCER;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; KAPLAN-MEIER ESTIMATE; LACTALBUMIN; MALE; MICE; MICE, TRANSGENIC; MUTATION; OLEIC ACIDS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84889631663     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303715     Document Type: Article

References (30)

1. Gangadhar T, Schilsky RL. Molecular markers to individualize adjuvant therapy for colon cancer. Nat Rev Clin Oncol 2010;7:318-25.
2. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
3. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009;361:2449-60.
4. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
5. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-4.
6. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-80.
7. Moon RT, Bowerman B, Boutros M, et al. The promise and perils of Wnt signaling through beta-catenin. Science 2002;296:1644-6. (Pubitemid 34579151)
8. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000;103:311-20.
9. Pettersson-Kastberg J, Aits S, Gustafsson L, et al. Can misfolded proteins be beneficial? The HAMLET case. Ann Med 2009;41:162-76.
10. Svanborg C, Agerstam H, Aronson A, et al. HAMLET kills tumor cells by an apoptosis-like mechanism-cellular, molecular, and therapeutic aspects. Adv Cancer Res 2003;88:1-29. (Pubitemid 36343277)
11. Fischer W, Gustafsson L, Mossberg AK, et al. Human alpha-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brain xenografts by an apoptosis-like mechanism and prolongs survival. Cancer Res 2004;64:2105-12. (Pubitemid 38339460)
12. Mossberg AK, Wullt B, Gustafsson L, et al. Bladder cancers respond to intravesical instillation of HAMLET (human alpha-lactalbumin made lethal to tumor cells). IntJ Cancer 2007;121:1352-9. (Pubitemid 47293805)
13. Gustafsson L, Leijonhufvud I, Aronsson A, et al. Treatment of skin papillomas with topical alpha-lactalbumin-oleic acid. N Engl J Med 2004;350:2663-72.
14. Storm P, Aits S, Puthia MK, et al. Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis. Oncogene 2011;30:4765-79.
15. Gustafsson L, Aits S, Onnerfjord P, et al. Changes in proteasome structure and function caused by HAMLET in tumor cells. PloS One 2009;4:e5229.
16. Svensson M, Hakansson A, Mossberg AK, et al. Conversion of alpha-lactalbumin to a protein inducing apoptosis. Proc Natl Acad Sci USA 2000;97:4221-6. (Pubitemid 30226114)
17. Koehl GE, Spitzner M, Ousingsawat J, et al. Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in ApcMin/+ mice. Oncogene 2010;29:1553-60.
18. Ilyas M, Tomlinson IP, Rowan A, et al. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 1997;94:10330-4. (Pubitemid 27407041)
19. Aberle H, Butz S, Stappert J, et al. Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J Cell Sci 1994;107:3655-63.
20. Steinhusen U, Badock V, Bauer A, et al. Apoptosis-induced cleavage of beta-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential. J Biol Chem 2000;275:16345-53. (Pubitemid 30366951)
21. Ikeda S, Kishida M, Matsuura Y, et al. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Oncogene 2000;19:537-45. (Pubitemid 30099367)
22. Zhao J, Yue W, Zhu MJ, et al. AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of beta-catenin at Ser 552. Biochem Biophys Res Commun 2010;395:146-51.
23. Kunzelmann K. Ion channels and cancer. J Membr Biol 2005;205:159-73. (Pubitemid 41803693)
24. Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006;25:7531-7. (Pubitemid 44885752)
25. Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003;116:2627-34. (Pubitemid 36857216)
26. Lepourcelet M, Chen YN, France DS, et al. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 2004;5:91-102. (Pubitemid 38121599)
27. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
28. Greenspan EJ, Madigan JP, Boardman LA, et al. Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}. Cancer Prev Res (Phila) 2011;4:161-71.
29. Fukuda K. Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells. Int J Biochem Cell Biol 1999;31:519-29. (Pubitemid 29112912)
30. Hallgren O, Aits S, Brest P, et al. Apoptosis and tumor cell death in response to HAMLET (human alpha-lactalbumin made lethal to tumor cells). Adv Exp Med Biol 2008;606:217-40.